CCL5 and hepatocellular carcinoma: We then performed bulk RNA sequencing (RNAseq) on CCL5‐stimulated Huh7 cells and discovered the CCL5/CCR5/CYP1A1 pathway, which may prompt the drug resistance of hepatoma cells to lenvatinib.